ALGS vs PNR · rev $2.8M vs P/E 18, rev $4.18B
Aligos Therapeutics Inc (ALGS) versus Pentair PLC (PNR) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Pentair PLC (PNR) is a specialty industrial machinery company listed on NYSE.
Latest reported ALGS revenue for 2026-06-30 was $2.8M. Net income was -$24.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALGS currently screens at market cap $44.1M.
Latest reported PNR revenue for 2025-12-31 was $4.18B. Net income was $653.8M. Revenue was up 2.3% from 2024-12-31 to 2025-12-31. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
ALGS currently screens at market cap $44.1M. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
Not investment advice. Open the ALGS and PNR stock pages for the full models.
Not investment advice.